Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Modifications in the RER01:26

Protein Modifications in the RER

5.1K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteoforms as the true units of physiological function.

European journal of applied physiology·2025
Same author

Ten "Cheat Codes" for Measuring Oxidative Stress in Humans.

Antioxidants (Basel, Switzerland)·2024
Same author

Oxiforms: Unique cysteine residue- and chemotype-specified chemical combinations can produce functionally-distinct proteoforms: Like how mixing primary colours creates new shades, cysteine residue- and chemotype-specified chemical combinations can produce functionally-distinct proteoforms called oxiforms: Like how mixing primary colours creates new shades, cysteine residue- and chemotype-specified chemical combinations can produce functionally-distinct proteoforms called oxiforms.

BioEssays : news and reviews in molecular, cellular and developmental biology·2023
Same author

To clot or not to clot? That is a free radical question.

The Journal of physiology·2018

Related Experiment Video

Updated: Jun 18, 2025

Resin-Assisted Capture Coupled with Isobaric Tandem Mass Tag Labeling for Multiplexed Quantification of Protein Thiol Oxidation
07:16

Resin-Assisted Capture Coupled with Isobaric Tandem Mass Tag Labeling for Multiplexed Quantification of Protein Thiol Oxidation

Published on: June 21, 2021

1.7K

Exploring the unmapped cysteine redox proteoform landscape.

James N Cobley1

  • 1School of Life Sciences, University of Dundee, Dundee, United Kingdom.

American Journal of Physiology. Cell Physiology
|August 5, 2024
PubMed
Summary

Cysteine redox proteoforms, the diverse molecular states of proteins, remain largely uncharted due to complexity. This review proposes new technologies and a Human Cysteine Redox Proteoform Project to map this landscape.

Keywords:
ROScysteineproteoformredox regulationtechnology

More Related Videos

Profiling Thiol Redox Proteome Using Isotope Tagging Mass Spectrometry
12:07

Profiling Thiol Redox Proteome Using Isotope Tagging Mass Spectrometry

Published on: March 24, 2012

16.2K
Combining Non-reducing SDS-PAGE Analysis and Chemical Crosslinking to Detect Multimeric Complexes Stabilized by Disulfide Linkages in Mammalian Cells in Culture
09:37

Combining Non-reducing SDS-PAGE Analysis and Chemical Crosslinking to Detect Multimeric Complexes Stabilized by Disulfide Linkages in Mammalian Cells in Culture

Published on: May 2, 2019

10.1K

Related Experiment Videos

Last Updated: Jun 18, 2025

Resin-Assisted Capture Coupled with Isobaric Tandem Mass Tag Labeling for Multiplexed Quantification of Protein Thiol Oxidation
07:16

Resin-Assisted Capture Coupled with Isobaric Tandem Mass Tag Labeling for Multiplexed Quantification of Protein Thiol Oxidation

Published on: June 21, 2021

1.7K
Profiling Thiol Redox Proteome Using Isotope Tagging Mass Spectrometry
12:07

Profiling Thiol Redox Proteome Using Isotope Tagging Mass Spectrometry

Published on: March 24, 2012

16.2K
Combining Non-reducing SDS-PAGE Analysis and Chemical Crosslinking to Detect Multimeric Complexes Stabilized by Disulfide Linkages in Mammalian Cells in Culture
09:37

Combining Non-reducing SDS-PAGE Analysis and Chemical Crosslinking to Detect Multimeric Complexes Stabilized by Disulfide Linkages in Mammalian Cells in Culture

Published on: May 2, 2019

10.1K

Area of Science:

  • Biochemistry
  • Proteomics
  • Molecular Biology

Background:

  • Cysteine residues in proteins can exist in multiple redox states, forming diverse cysteine redox proteoforms.
  • The theoretical number of proteoforms increases exponentially with the number of cysteine residues, creating a vast and complex landscape.
  • Despite their biological importance, the full extent of cysteine redox proteoforms and their regulatory roles are poorly understood.

Purpose of the Study:

  • To advance the theory of cysteine redox proteoforms.
  • To scrutinize existing methodological challenges in their detection.
  • To propose innovative technologies and a community-wide project for systematic exploration.

Main Methods:

  • Review and synthesis of current knowledge on cysteine redox proteoforms.
  • Discussion of limitations in existing analytical techniques.
  • Elaboration of chemistry-enabled hybrid approaches, combining top-down mass spectrometry (TD-MS) and bottom-up mass spectrometry (BU-MS).

Main Results:

  • The theoretical cysteine redox proteoform landscape is vast and largely uncharted.
  • Existing methods face significant challenges in comprehensively detecting unique residue-defined proteoforms.
  • Hybrid TD-MS and BU-MS approaches offer a technological pathway to map this complex redox terrain.

Conclusions:

  • Exploring the cysteine redox proteoform landscape is crucial for understanding redox biology.
  • Innovative technologies and collaborative efforts like the proposed Human Cysteine Redox Proteoform Project are needed.
  • Mapping cysteine redox proteoforms could reveal novel regulatory mechanisms, biomarkers, and therapeutic targets.